Preventive and Therapeutic Strategies for Bovine Leukemia Virus: Lessons for HTLV
Open Access
- 18 July 2011
- Vol. 3 (7), 1210-1248
- https://doi.org/10.3390/v3071210
Abstract
Bovine leukemia virus (BLV) is a retrovirus closely related to the human T-lymphotropic virus type 1 (HTLV-1). BLV is a major animal health problem worldwide causing important economic losses. A series of attempts were developed to reduce prevalence, chiefly by eradication of infected cattle, segregation of BLV-free animals and vaccination. Although having been instrumental in regions such as the EU, these strategies were unsuccessful elsewhere mainly due to economic costs, management restrictions and lack of an efficient vaccine. This review, which summarizes the different attempts previously developed to decrease seroprevalence of BLV, may be informative for management of HTLV-1 infection. We also propose a new approach based on competitive infection with virus deletants aiming at reducing proviral loads.Keywords
This publication has 271 references indexed in Scilit:
- BLV-CoCoMo-qPCR: Quantitation of bovine leukemia virus proviral load using the CoCoMo algorithmRetrovirology, 2010
- DNA Cytosine Methylation in the Bovine Leukemia Virus Promoter Is Associated with Latency in a Lymphoma-derived B-cell LinePublished by Elsevier BV ,2010
- Mechanisms of HTLV-1 persistence and transformationBritish Journal of Cancer, 2009
- Even Attenuated Bovine Leukemia Virus Proviruses Can Be Pathogenic in SheepJournal of Virology, 2007
- Complete suppression of viral gene expression is associated with the onset and progression of lymphoid malignancy: observations in Bovine Leukemia Virus-infected sheepRetrovirology, 2007
- Suppression of Viral Gene Expression in Bovine Leukemia Virus-Associated B-Cell Malignancy: Interplay of Epigenetic Modifications Leading to Chromatin with a Repressive Histone CodeJournal of Virology, 2007
- Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in humanRetrovirology, 2007
- In vitroPeptide Immunization of Target Tax Protein Human T-Cell Leukemia Virus Type 1–Specific CD4+ Helper T LymphocytesClinical Cancer Research, 2006
- HTLV-1 propels untransformed CD4+ lymphocytes into the cell cycle while protecting CD8+ cells from deathJCI Insight, 2006
- Epigenetic therapy of cancer: past, present and futureNature Reviews Drug Discovery, 2006